Ehrentraud Eichelbaum, MD
General Practice · Bushnell, FLNPI 1255518486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $984 and has fallen 93.5% since, to $64 in 2025. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$702
- GSK$573
- Novartis$308
- AbbVie$265
- Bayer$228
- Esperion Therapeutics, Inc.$183
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$221%
- Food & beverage$3,44599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $702 |
| GSK | 30 | $573 |
| Novartis | 17 | $308 |
| AbbVie | 14 | $265 |
| Bayer | 10 | $228 |
| Esperion Therapeutics, Inc. | 8 | $183 |
| Novo Nordisk | 11 | $165 |
| Pfizer | 8 | $162 |
| Johnson & Johnson(2 entities) | 8 | $161 |
| Lilly USA, LLC | 11 | $131 |
| Sunovion Pharmaceuticals Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Greenwich Biosciences, Inc. | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Acorda Therapeutics, Inc | 1 | $22 |
| Amgen | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Biogen | 1 | $14 |
| Abbott | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
How this compares
$3,467 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other general practice in Bushnell
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
- Rickie FergusonPembroke Pines$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.